Skip to main content
Hospital for Special Surgery Logo
phone 1.212.606.1000
Make an Appointment
1.212.606.1000 Make an Appointment

HSS Research Institute

Since its founding more than 150 years ago, Hospital for Special Surgery has been a leader in research aimed at improving the lives of patients suffering from debilitating orthopedic and rheumatic conditions such as arthritis, bone and soft tissue injuries, autoimmune diseases, and musculoskeletal pain and deformities.

Today, the HSS Research Institute, with over 225 dedicated personnel, is identifying mechanisms underlying these conditions, and developing effective approaches for prevention, diagnosis, and treatment. With a focus on tissue repair, improving surgical outcomes, autoimmunity and inflammation, genomics, new treatments, and precision medicine, the impact of our discoveries – many of which are only happening at HSS – determine future directions of musculoskeletal research to best improve clinical outcomes.

$64M

Active Federal Grants Funding

1200

Publications in 2023

$35M

Active Foundation & Industry Funding

Movement is the Essence of Life

Dr. Ivashkiv

We are embarking on a new era of research at HSS by expanding the scope of basic and clinical science and building multidisciplinary translational research teams.
Lionel Ivashkiv, MD Chief Scientific Officer

Research Areas

Soft Tissue

Biomechanics

Genomics

MRI Research

Bone Health and Spine Regeneration

Making bones better

HSS scientists conducting research in this area are uncovering the nature of bone – how it thrives, how it degenerates, and how it interacts with soft tissues like cartilage, ligaments, and tendons, as well as orthopaedic devices such as implants. Understanding the mechanisms that regulate bone structure and function is critical for determining how and why skeletal disorders occur and for developing new treatments for these disorders. Scientists in this area are performing cutting-edge research to enhance mobility and improve quality of life for patients affected by bone disorders such as spine instability, fractures, developmental deformities, arthritis, and osteoporosis.

Arthritis and Tissue Degeneration Program

Arthritis and Tissue Degeneration Program
- Carl Blobel, MD, PhD, Director

The mission of the Arthritis and Tissue Degeneration Program is to define cellular and molecular mechanisms important in musculoskeletal tissue destruction and to develop novel approaches to preventing tissue destruction in patients with arthritis and related diseases.

Program Overview

Musculoskeletal Integrity Program

Musculoskeletal Integrity Program

The Musculoskeletal Integrity Program's mission is to determine the biological, biochemical, and biomechanical mechanisms involved in musculoskeletal tissue development, degeneration, and repair, and to use that information to develop therapies to prevent or correct conditions in which these processes are impaired.

Program Overview

Autoimmunity and Inflammation

Targeting the immune system

The cells of the immune system function together in a highly complex network to protect the body against infections. When control of the immune system is impaired, autoimmunity and tissue damage due to inflammation can result. Scientists in this area are focused on understanding the disease-causing mechanisms and developing more effective therapies. With millions of patients worldwide suffering from rheumatoid arthritis, lupus, and other chronic autoimmune and inflammatory diseases, these scientists are working hard to develop better treatments and, ultimately, cures.

Autoimmunity and Inflmmation Program

Autoimmunity and Inflammation Program
- Mary K. Crow, MD, Director

The investigators of the Autoimmunity and Inflammation Research Program at Hospital for Special Surgery study the basic mechanisms of immune system function and the role of altered immune system activation, regulation, and effector function in the pathogenesis of the systemic autoimmune and inflammatory diseases.

Program Overview

 

Arthritis and Tissue Degeneration Program

Arthritis and Tissue Degeneration Program
- Carl Blobel, MD, PhD, Director

The mission of the Arthritis and Tissue Degeneration Program is to define cellular and molecular mechanisms important in musculoskeletal tissue destruction and to develop novel approaches to preventing tissue destruction in patients with arthritis and related diseases.

Program Overview

Precision Medicine

Making health care personal

In response to the great promise that precision medicine holds, HSS has created a Precision Medicine Laboratory that will enable the study of disease mechanisms, surgical outcomes, and responses to therapy in specific patient populations. The Laboratory catalyzes the formation of multidisciplinary teams of scientists, physicians, and orthopaedic surgeons, linking clinical research with exciting basic science research. HSS will use the precision medicine approach to pinpoint the most personalized treatment plan for the patient – ultimately allowing physicians to select the right treatment the first time and improving outcomes.

Icon image

Precision Medicine Laboratory
- Laura Donlin, PhD and Miguel Otero, PhD, Directors

Through the HSS Precision Medicine Laboratory, multidisciplinary clinician-scientist teams comprehensively study orthopedic and autoimmune disorders. Through integrative and cutting-edge approaches, we aim to discover the best treatment for each patient.

Program Overview

 

Basic and Translational Research

Programs

Faculty

Postdoctoral Program

Postbaccalaureate Program

 

Contact Us: 212.774.7123

Events

HSS Research Day took place on Thursday, May 9, 2024 featuring keynote speaker John Varga, M.D., FACP, MACR, Frederick G L Huetwell, Professor of Rheumatology, Professor of Internal Medicine, Chief, Division of Rheumatology, University of Michigan.

HSS Research In the News